A Retrospective Non-intervention Study to Characterize FOlate Rescue Treatment in Osteosarcoma Patients Treated With HDMTX

• Status: Completed
• Trial end date: 2016-05-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to investigate to which extend osteosarcoma patients do NOT meet the criteria for successfully advancement to next planned chemotherapy course.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Isofol Medical AB
• Treatments: Methotrexate

Criteria

Inclusion Criteria:

• Patients must have histological evidence of osteosarcoma including metastatic osteosarcoma.

• Patients must have initiated their HDMTX treatment after 01 January 2009 and should have completed their MAP treatment by 31 May 2014.

• Patients should have received at least one (1) HDMTX course within MAP treatment.

• Patients must be at least 2 years of age.

• Patient, parent(s), or guardian(s), as appropriate, is/are willing to provide signed informed consent, if applicable according to national regulation.

Exclusion Criteria:

• No exclusion criteria